The online pipeline is undergoing construction. Please refer to this PowerPoint for most up-to-date pipeline.

View Discovery

Clinical Pipeline

Submitted for Registration Download PPT


PanACEA, St. George's Hospital University of London

Pre-Clinical (GLP)


GlaxoSmithKline
Innovative Medicines for Tuberculosis (iM4TB)
Global Alliance for TB Drug Development
Medical Centre of the University of Munich (LMU), Hans-Knöll-Institut (HKI), German Center for Infection Research (DZIF)

Phase 1


Qurient Co., Ltd, Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
Nearmedic Plus LLC
Otsuka Pharmaceutical Development & Commercialization, Inc.